Dental products company Dentsply Sirona (NASDAQ:XRAY) announced in Q1 CY2025, but sales fell by 7.8% year on year to $879 million. The company’s full-year revenue guidance of $3.65 billion at the ...

Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. The dental equipment and ...

Analysts' ratings for Dentsply Sirona (NASDAQ:XRAY) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The table below provides a concise overview of recent ratings by ...

Dentsply Sirona topped Q1 estimates, raised 2025 sales outlook, and reaffirmed EPS guidance, pushing shares higher despite ...

We recently published a list of Smart Money Ratings For 20 Most Undervalued Stocks. In this article, we are going to take a ...

In this article, we are going to take a look at where Dentsply Sirona Inc. (NASDAQ:XRAY) stands against other Thursday’s top-performing stocks. The stock market extended its winning streak on ...

What Propelled Double-Digit Gains? In this article, we are going to take a look at where Dentsply Sirona Inc. (NASDAQ:XRAY) ...